1. Home
  2. XPER vs FENC Comparison

XPER vs FENC Comparison

Compare XPER & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xperi Inc.

XPER

Xperi Inc.

HOLD

Current Price

$5.48

Market Cap

259.7M

Sector

Technology

ML Signal

HOLD

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

HOLD

Current Price

$5.95

Market Cap

266.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPER
FENC
Founded
1990
1996
Country
United States
United States
Employees
1460
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.7M
266.4M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
XPER
FENC
Price
$5.48
$5.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$11.00
$15.00
AVG Volume (30 Days)
367.9K
186.4K
Earning Date
05-06-2026
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
96.67
EPS
N/A
N/A
Revenue
$448,105,000.00
$47,538,000.00
Revenue This Year
$4.03
$75.81
Revenue Next Year
$8.11
$25.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
123.69
52 Week Low
$5.07
$4.68
52 Week High
$8.24
$9.92

Technical Indicators

Market Signals
Indicator
XPER
FENC
Relative Strength Index (RSI) 40.99 31.07
Support Level $5.07 N/A
Resistance Level $6.37 $8.27
Average True Range (ATR) 0.19 0.49
MACD -0.05 -0.19
Stochastic Oscillator 4.41 2.21

Price Performance

Historical Comparison
XPER
FENC

About XPER Xperi Inc.

Xperi Inc is a media and entertainment technology company. Its technologies are integrated into consumer devices, connected cars, and a variety of media platforms globally, enabling audiences to connect with entertainment content in a more intelligent, immersive, and personal way. As its audiences engage with content on the platform, the company operates a cross-screen advertising solution that enables brands to reach millions of engaged consumers across rapidly expanding digital entertainment ecosystem. It operates in one reportable business segment and group its revenue into four categories: Pay-TV, Consumer Electronics, Connected Car and Media Platform. Geographically it operates in U.S. and Canada, Asia Pacific, Europe, Middle East and Africa, and Other countries.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: